A 52-year-old womanwas diagnosed as having cerebellar ataxia, hypogonadotropic hypogonadism and retinochoroidal degeneration, the so-called, "Boucher-Neuhauser" syndrome proposed by Limber et al (Am J Med Genet 33: 409, 1989). In addition, laboratory findings showed the elevation of serum calcium (Ca) levels, low urinary Ca excretion, and exaggerated reabsorption of filtrated Ca (FECa: 0.14 %), suggesting complication ofhypocalciuric hypercalcemia. This is a very rare case of Boucher-Neuhauser syndromeassociated with hypocalciuric hypercalcemia.
Introduction
The systematized cerebellar degenerations form a group which are difficult to clarify, and in most cases, etiology remains unknown. Corticocerebellar atrophy (CCA) and olivocerebellar atrophy (OCA) most probably represent the same degenerative disorder. They are characterized by the appearance of a pure progressive pan cerebellar syndrome associated with an autosomal dominant inheritance. Occasional sporadic cases also mayoccur. The age of onset is usually in the fourth to sixth decades, but onset as early as the second and as late as the seventh decade has been reported, and the duration of the illness is 10 to 20 years. The patient first develops a gait unsteadiness and primarily a paleocerebellar syndrome. This progresses on to dysarthria and then finally ataxia of the upper extremities and trunk. In advanced stages, there may be weakness of the legs, rigidity, nystagmus, and oculomotor palsies. Optic atrophy occurs frequently in some families, but is not found in others. The reflexes maybe reduced or hyperactive. Ankle clonus and extensor plantar responses are found in some cases. Mental deterioration may occur late. Holmes (1) first described a kindred with this disease entity. Since this was a familial disease, he thought this was a separate entity from olivopontcerebellar atrophy. In his original paper, Holmes also demonstrated the association of hypogonadismwith cerebellar ataxia. Since then, various combinationsof cerebellar ataxia and hypogonadism have been reported (2) (3) (4) (5) (6) (7) (8) (9) (10) Case Report
A 52-year-old woman, the product of a normal pregnancy and delivery was admitted to our hospital for evaluation of an unsteady gait, recurrent bone fractures, and hypercalcemia in June 1993. There was consanguinity between the parents. She first noticed unsteady gait and hair loss at the age of around 20 years. She never menstruated. She had been treated for primary amenorrhea for 6 years from the age of28 years, and had a child at the age of 35 years. Renal dysfunction and hypercalcemia were pointed out at the age of41 years. At the age of46 years, she suffered twice from compression fractures of lumbar verte- 8.7-38.0 mlU/ml) and follicle-stimulating hormone (FSH), 0.5 mlU/ml (normal postmenopausal: 26.2-1 1 3.3 mlU/ml) levels, which was consistent with hypogonadotropic hypogonadism. Serum progesterone level was <0.2 ng/ml (normal: 0.2-31.6 ng/ml). Serum growth hormone (GH) level was 0.29 ng/ml (normal: 0.66-3.68 ng/ml). The basal level of other hormones was within the normal limit. Pituitary hormoneresponses to provocation tests are shown in Table 2 . Serum LHand FSH, 7 1±3%), respectively, suggesting osteoporotic change.
Discussion
The case described here revealed various clinical manifestations including hypogonadotropic hypogonadism, retinochoroidal degeneration, cerebellar ataxia without spinal tract involvement. In addition, the elder sister of the patient, who is nowunder medical evaluation showedalmost the same clinical history and symptoms. In consideration of this case together with previously reported cases, it seems reasonable to assume that the triad of manifestations such as hypogonadotropic hypogonadism, retinochoroidal degeneration and cerebellar ataxia is secondary to dysfunction of the same gene. The only difference between this case and previous cases is the association of hypocalciuric hypercalcemia. The existence of consanguinity between the parents suggests an autosomal recessive pattern of inheritance. Reported cases of ataxia and hypogonadotopic hypogonadism are reviewed in Table 4 . Most published families are compatible with autosomal recessive inheritance, although Volpe et al (2) reported a family for which X-linked recessive inheritance was suggested. The association of hypogonadismwith cerebellar or spinocerebellar ataxia was (4, 5) . In this case, the responses of LH and FSH to LH-RH(100 jig) were impaired even after repetitive stimulation with LH-RH(400 jag, 7 days), strongly pointing to pituitary hypogonadism. Furthermore, GHresponses to GRF (100 jig) and insulin-induced hypoglycemia (regular insulin 0.1 U/kg) were blunted, and peak ACTHresponse to insulin-induced hypoglycemia (regular insulin 0. 1 U/kg) was obtained at 60 minutes. This pattern of response is presumptive evidence of hypothalamic dysfunction. These results showed that the defect is not confined to the pituitary but involves the hypothalamusas well. The absence of lesions in the pituitary and hypothalamus on CT and MRIof the brain suggested that the defect is a functional one rather than a structural one. The patient was assumed to be under postmenopausal state for more than 10 years and the lack of estrogen seemed to have an important pathogenetical role in several aspects. Frantz and Rabkin (ll) have postulated that estrogens act to enhance pituitary sensitivity, or that of higher centers, to the GHreleasing effects of physical activity and possibly other stimuli. Therefore, the impaired responses of GHto GRFand the insulin-induced hypoglycemia in this patient could be, at least in part, explained by estrogen deficiency, although there might be' a widespread hypothalamo-pituitary disorder. Marked hyperlipidemia and hyperuricemia mayalso be attributed to estrogen deficiency. Ma et al (12) showed that the level of mRNAfor low density lipoprotein (LDL) receptor increased 6-to 8-fold in the liver of rabbits treated with estradiol and that the increase in the receptor number was correlated with that in the mRNA.Mabuchi et al (13) observed, in one patient with heterozygous familial hypercholesterolemia, that the serum cholesterol level and LDLcholesterol level were decreased by 63% and 83%, respectively, during pregnancy, and by 25% and 40%, respectively, in the non-pregnant state following treatmentwith estradiol. They considered that the reduction in the serum cholesterol level during pregnancy was probably brought about by the action ofestrogens. Furthermore, Shiomi et al ( 14) suggested that in homozygous Watanabe heritable hyperlipidemic (WHHL) rabbits, the decrease in the serum cholesterol level during pregnancy is closely associated with an increase in hepatic LDLreceptor activity, and that the increase in hepatic LDLreceptor activity during pregnancy may be due to the action of estrogens. In addition, exogenous estradiol suppressed the activity of hepatic lipase, which is thought to have a physiological role in regulating the conversion of very low density lipoprotein (VLDL) and intermediate density lipoprotein (IDL) to LDL, leading to a decreased synthesis of LDL-cholesterol and total cholesterol ( 1 5). On the other hand, it has been well knownthat there is a sex difference in uric acid metabolism. The average serum uric acid level of men is somewhat higher than that of women. Mikkelsen et al (16) performed serum uric acid determinations in order to define the distribution characteristics of serumuric acid levels in a natural population, and? to evaluate the importance of age and sex as variables in relation to the serum uric acid level. For female subjects, there was a slightrise in serum uric acid values beyond puberty but the curve shortly fell again and plateaus at a level of abut 4.0 mg/dl until the age of menopause, when it rose gradually to approach closely that of male subjects in the early fifties. So, it is reasonable to speculate that estrogens mayhave a role for preventing the elevation of serum uric acid level possibly by increasing uric acid clearance from blood or by blocking synthesis of uric acid. Markedosteoporosis is also observed in this patient. Estrogen increases bone mass by suppressing bone turnover through several mechanisms as follows: estrogen acts directly on humanbone cells through a classical estrogen receptor-mediated mechanism (17, 1 8). 17B-Estradiol has direct effects on bone which are consistent with its known effects to decrease bone resorption (19) . And estrogen inhibits the production ofinterleukin I, one of the pathogenetical factors of osteoporosis in monocytes (20) . For the reasons described above, long-term estrogen deficiency accelerates osteoporosis and other metabolic disorders. The cause ofhypocalciuric hypercalcemiaremains unknown.
Usually hypocalciuric hypercalcemia is a familial disease with autosomal dominant inheritance (21) (22) (23) (24) Roentgenographical findings showed no swelling of parathyroid gland, so primary hyperparathyroidism also seems unlikely although a slight elevation of serum PTHlevels was noted.
Mostpatients with postmenopausalosteoporosis have normal or low values for serum PTH,but a small subset ofosteoporotic patients have increased PTHvalues (27, 28). Riggs et al (28) suggested that the increased serum PTHlevel in osteoporotic patients is caused by secondary hyperparathyroidism rather than by normocalcemic primary hyperparathyroidism. The fact that the present patient suffered from renal dysfunction (Ccr 43 ml/min) may support this hypothesis. It is now established that native vitamin D is biologically inactive and must undergo hydroxylation at the 25-position in the liver and at the 1-position in the kidney to produce 1,25(OH)2D, the physiologically important, active form of the vitamin (29). Pike et al (30) demonstrated that estrogen modulates renal 25-OH-D3-lahydroxylase, the enzyme responsible for the metabolic conversion of25-OH-D to 1 ,25(OH)2D, leading to increased intestinal Ca absorption. Therefore, a relatively low serumlevel of 1 ,25(OH)2D noted in the patient could be also explained by the lack of estrogen. In consideration of these various findings, one possible explanation for hypocalciuric hypercalcemia is that exaggerated reabsorption ofFECa may be a kind of compensatory adaptation to maintain Ca homeostasis. Further studies are necessary to clarify this mechanism. Wereport here a very rare case of Boucher-Neuhauser syndrome associated with hypocalciuric hypercalcemia. To date, a review of the literature reveals only 3 reports compatible with this syndrome (8) (9) (10) and endocrinological evaluation of patients with this syndrome were quite incomplete. It should be emphasized that careful endocrinological evaluation of patients with this syndrome maycontribute to further understanding of the pathogenetical basis of this new disease entity.
